Metraipolis › archive › dc_8501e557d2b5

Characteristics and outcomes of patients treated with tigecycline for MDR gram-negative infections: a retrospective cohort study — Europe PMC PMID:41994202

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41994202
DOI
10.3389/fcimb.2026.1790441
License (as archived)
solo-consultazione
Archived
2026-11-03T13:26:31.103Z
SHA-256 of the archived text
b3c782141f769a5d0ae59eb88fe3169ac295827806d55cafcad8e2c91c18aa37
Stable URL of this page
https://metraipolis.com/documento/dc_8501e557d2b5

How to cite

Characteristics and outcomes of patients treated with tigecycline for MDR gram-negative infections: a retrospective cohort study — Europe PMC PMID:41994202 — Europe PMC (en), https://europepmc.org/article/MED/41994202 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8501e557d2b5 (Metraipolis archive dc_8501e557d2b5, sha256 b3c782141f769a5d0ae59eb88fe3169ac295827806d55cafcad8e2c91c18aa37)
BibTeX
@misc{dc8501e557d2b5,
  title = {Characteristics and outcomes of patients treated with tigecycline for MDR gram-negative infections: a retrospective cohort study — Europe PMC PMID:41994202},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41994202},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8501e557d2b5; sha256 b3c782141f769a5d0ae59eb88fe3169ac295827806d55cafcad8e2c91c18aa37},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41994202. Agents can read the archived copy with the MCP tool read_document.